Compensation of Executive Officers
The following table shows for the fiscal years ended December 31, 2014, 2013, and 2012, compensation
awarded to or paid to, or earned by, our Chief Executive Officer, Chief Financial Officer and our three other
most highly compensated executive officers at December 31, 2014, called our ‘‘named executive officers.’’
Summary Compensation Table
Name and Principal
Position
Year
Salary
($)
Bonus
(1)
($)
Stock
Awards
(2)
($)
Option
Awards
(2)
($)
All Other
Compensation
(3)
($)
Total
($)
Stanley T. Crooke . . . . . . . . . . . . . . . . . 2014 $768,252 $720,236 $1,489,375 $3,231,294
$18,986 $6,228,143
Chairman, President,
2013 $735,169 $803,907 $ 325,971 $ 877,737
$15,752 $2,758,536
Chief Executive Officer
2012 $735,169 $367,585 $ 90,516 $ 344,921
$17,815 $1,556,006
Elizabeth L. Hougen . . . . . . . . . . . . . . . 2014 $377,923 $206,677 $ 357,450 $ 775,511
$23,981 $1,741,542
Senior Vice President, Finance and
2013 $365,496 $215,871 $ 54,419
(4)
$ 113,461
(4)
$20,618 $ 769,865
Chief Financial Officer
2012 $337,036 $131,444 $ 16,462 $ 62,741
$21,148 $ 568,831
B. Lynne Parshall . . . . . . . . . . . . . . . . . 2014 $664,029 $466,895 $ 655,325 $1,421,771
$24,023 $3,232,043
Director, Chief Operating Officer
2013 $641,574 $526,171 $ 152,482 $ 410,463
$20,636 $1,751,326
2012 $641,574 $256,630 $ 52,136 $ 198,675
$22,600 $1,171,615
Richard S. Geary. . . . . . . . . . . . . . . . . . 2014 $411,194 $224,872 $ 357,450 $ 775,511
$16,861 $1,785,888
Senior Vice President, Development
2013 $398,444 $225,918 $ 82,117 $ 221,049
$14,695 $ 942,223
2012 $398,444 $143,440 $ 23,583 $ 89,879
$17,048 $ 672,394
Brett Monia
(5)
. . . . . . . . . . . . . . . . . . . 2014 $396,158 $233,981 $ 357,450 $ 775,511
$24,015 $1,787,115
Senior Vice President, Drug Discovery 2013 $381,288 $142,983 $ 83,145 $ 224,081
$22,834 $ 854,331
and Corporate Development
(1) We present bonuses in the years they were earned, not in the year paid. Bonuses represent compensation for achievements and are not
necessarily paid in the year they are earned; for example, in January 2015 we paid bonuses for 2014 performance.
(2) Amounts represent the aggregate expense recognized for financial statement reporting purposes in accordance with FASBTopic
ASC 718 (‘‘ASC 718’’) for stock and option awards granted to our named executive officers. ASC 718 expense for the option awards
is based on the fair value of the awards on the date of grant using an option-pricing model. The fair value of RSUs is based on the
market price of our common stock on the date of grant. For more information, please see Note 5,
Stockholders’ Equity
, regarding
assumptions underlying valuation of equity awards.
(3) Includes AD&D, Basic Life, Medical, Dental, Vision, and 401(k) matching contributions which are available to all employees.
(4) Ms. Hougen received additional stock options and stock awards due to her promotion to Chief Financial Officer in January 2013.
(5) Mr. Monia was not a named executive officer in 2012 or 2013. We are not disclosing compensation for 2012 as permitted by SEC
regulations.
112
